FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Girolamo Calò

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Michele Caselli; Francesca Cassol; John Holton; Giovanni Zuliani; Girolamo Calò; Antonio Gasbarrini
Actual concept of "probiotics": is it more functional to science or business?
M Marti; Flora Mela; S Molinari; Paola Petrillo; Silvio Ronzoni; M Volta; N T Zaveri; M Budri; Girolamo Calò; D Malfacini; Michele Morari
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111.
Michele Caselli; John Holton; Dino Vaira; Paola Boldrini; Girolamo Calò
Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum: implications for the relationship with the immune system.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Girolamo Calò (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michele Caselli; Francesca Cassol; John Holton; Giovanni Zuliani; Girolamo Calò; Antonio Gasbarrini
Actual concept of "probiotics": is it more functional to science or business?
World journal of gastroenterology : WJG 2013;19(10):1527-40.
2013: M Marti; Flora Mela; S Molinari; Paola Petrillo; Silvio Ronzoni; M Volta; N T Zaveri; M Budri; Girolamo Calò; D Malfacini; Michele Morari
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111.
British journal of pharmacology 2013;168(4):863-79.
2010: Michele Caselli; John Holton; Dino Vaira; Paola Boldrini; Girolamo Calò
Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum: implications for the relationship with the immune system.
Gut microbes 2010;1(6):367-72.
2009: Valeria Camarda; Anna Rizzi; Chiara Ruzza; Silvia Zucchini; Giuliano Marzola; Erika Marzola; Remo Guerrini; Severo Salvadori; Rainer K Reinscheid; Domenico Regoli; Girolamo Calò
In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
The Journal of pharmacology and experimental therapeutics 2009;328(2):549-55.
2009: Remo Guerrini; Valeria Camarda; Claudio Trapella; Girolamo Calò; Anna Rizzi; Chiara Ruzza; Stella Fiorini; Erika Marzola; Rainer K Reinscheid; Domenico Regoli; Severo Salvadori
Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
Journal of medicinal chemistry 2009;52(2):524-9.
2007: Marika Arduin; Barbara Spagnolo; Girolamo Calò; Remo Guerrini; Giacomo Carrà; Carmela Fischetti; Claudio Trapella; Erika Marzola; John McDonald; David G Lambert; Domenico Regoli; Severo Salvadori
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.
Bioorganic & medicinal chemistry 2007;15(13):4434-43.
2007: Barbara Spagnolo; Giacomo Carrà; Martina Fantin; Carmela Fischetti; Christopher P Hebbes; John McDonald; Timothy A Barnes; Anna Rizzi; Claudio Trapella; Giulia Fanton; Michele Morari; David G Lambert; Domenico Regoli; Girolamo Calò
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
The Journal of pharmacology and experimental therapeutics 2007;321(3):961-7.
2007: Anna Rizzi; Elaine Gavioli; Giuliano Marzola; Barbara Spagnolo; Silvia Zucchini; Roberto Ciccocioppo; Claudio Trapella; Domenico Regoli; Girolamo Calò
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.
The Journal of pharmacology and experimental therapeutics 2007;321(3):968-74.
2006: Massimo Lazzeri; Girolamo Calò; Michele Spinelli; Silvia Malaguti; Remo Guerrini; Severo Salvadori; Patrizia Beneforti; Domenico Regoli; Damiano Turini
Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study.
The Journal of urology 2006;176(5):2098-102.
2006: Letizia Penolazzi; Eros Magri; Elisabetta Lambertini; Girolamo Calò; Mauro Cozzani; Giuseppe Siciliani; Roberta Piva; Roberto Gambari
Local in vivo administration of a decoy oligonucleotide targeting NF-kappaB induces apoptosis of osteoclasts after application of orthodontic forces to rat teeth.
International journal of molecular medicine 2006;18(5):807-11.
2006: Ozge Gunduz Cinar; Anna Rizzi; Anna Baldisserotto; Remo Guerrini; Barbara Spagnolo; Elaine Gavioli; László Kocsis; Attila Magyar; Sándor Benyhe; Anna Borsodi; Girolamo Calò
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.
European journal of pharmacology 2006;539(1-2):39-48.
2006: Ozge Gunduz; Ferenc Sipos; Ozge Gunduz Cinar; László Kocsis; Attila Magyar; György Orosz; Anna Borsodi; Girolamo Calò; Sándor Benyhe
In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor.
Neuro-Signals 2006;15(2):91-101.
2006: Valeria Camarda; Martina Spagnol; Wei Song; Raffaella Vergura; Adelheid L Roth; Jonathan P Thompson; David J Rowbotham; Remo Guerrini; Erika Marzola; Severo Salvadori; Paolo Cavanni; Domenico Regoli; Stephen Douglas; David G Lambert; Girolamo Calò
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803).
British journal of pharmacology 2006;147(1):92-100.
2005: Teodorico Tancredi; Giacomo Carrà; Remo Guerrini; Marika Arduin; Girolamo Calò; Domenico Regoli; Severo Salvadori; Piero A Temussi
The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ.
Chemistry (Weinheim an der Bergstrasse, Germany) 2005;11(7):2061-70.
2004: Matteo Marti; Flora Mela; Remo Guerrini; Girolamo Calò; Clementina Bianchi; Michele Morari
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release.
Journal of neurochemistry 2004;91(6):1501-4.
2003: Massimo Lazzeri; Girolamo Calò; Michele Spinelli; Remo Guerrini; Severo Salvadori; Patrizia Beneforti; Sandro Sandri; Domenico Regoli; Damiano Turini
Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study.
Urology 2003;61(5):946-50.
2002: Valeria Camarda; Remo Guerrini; Evi Kostenis; Anna Rizzi; Girolamo Calò; Almut Hattenberger; Marina Zucchini; Severo Salvadori; Domenico Regoli
A new ligand for the urotensin II receptor.
British journal of pharmacology 2002;137(3):311-4.
2002: Valeria Camarda; Anna Rizzi; Girolamo Calò; Gabrielle Gendron; Stephan I Perron; Evi Kostenis; Clive Beggs; Francesco Mascoli; Domenico Regoli
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(2):141-9.
2001: Massimo Lazzeri; Girolamo Calò; Michele Spinelli; Remo Guerrini; Patrizia Beneforti; Sandro Sandri; Alberto Zanollo; Domenico Regoli; Damiano Turini
Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study.
The Journal of urology 2001;166(6):2237-40.
2001: Anna Rizzi; Giuliano Marzola; Raffaella Bigoni; Remo Guerrini; Severo Salvadori; J S Mogil; Domenico Regoli; Girolamo Calò
Endogenous nociceptin signaling and stress-induced analgesia.
Neuroreport 2001;12(14):3009-13.
2001: Massimo Gallerani; R Manfredini; D Dal Monte; Girolamo Calò; V Brunaldi; M Simonato
Circadian differences in the individual sensitivity to opiate overdose.
Critical care medicine 2001;29(1):96-101.
1999: C Rizzi; Anna Rizzi; Girolamo Calò; G Jorizzo; G Agnello; Gioacchino Mollica; N Inamura; Domenico Regoli
Characterization of FR 172357, a new non-peptide bradykinin B(2) receptor antagonist, in human, pig and rabbit preparations.
European journal of pharmacology 1999;386(1):25-31.
1999: Paolo Colamussi; Girolamo Calò; S Sbrenna; Licia Uccelli; Clementina Bianchi; Corrado Cittanti; Anna Siniscalchi; Melchiore Giganti; R Roveri; Adriano Piffanelli
New insights on flow-independent mechanisms of 99mTc-HMPAO retention in nervous tissue: in vitro study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(9):1556-62.
1999: Anna Rizzi; Girolamo Calò; Marcello Trevisani; Michele Tognetto; L Fabbri; Cristina E Mapp; Remo Guerrini; Severo Salvadori; Domenico Regoli; Pierangelo Geppetti
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus.
Life sciences 1999;64(13):PL157-63.
1998: Anna Rizzi; D Quaglio; Giorgio Vasquez; Francesco Mascoli; Silvia Amadesi; Girolamo Calò; Domenico Regoli; Clive Beggs
Effects of vasoactive agents in healthy and diseased human saphenous veins.
Journal of vascular surgery 1998;28(5):855-61.
1998: Girolamo Calò; Anna Rizzi; Giuliano Marzola; Remo Guerrini; Severo Salvadori; Lorenzo Beani; Domenico Regoli; Clementina Bianchi
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay.
British journal of pharmacology 1998;125(2):373-8.
1998: S Sbrenna; Girolamo Calò; Anna Siniscalchi; I Badini; Clementina Bianchi; Lorenzo Beani
Experimental protocol for studying delayed effects of in vitro ischemia on neurotransmitter release from brain slices.
Brain research. Brain research protocols 1998;3(1):61-7.
1997: Stefania Gessi; Anna Rizzi; Girolamo Calò; G Agnello; G Jorizzo; Gioacchino Mollica; Pier Andrea Borea; Domenico Regoli
Human vascular kinin receptors of the B2 type characterized by radioligand binding.
British journal of pharmacology 1997;122(7):1450-4.
1997: Anna Rizzi; Girolamo Calò; Silvia Amadesi; Domenico Regoli
Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(5):662-70.
1997: Domenico Regoli; Anna Rizzi; Girolamo Calò
Pharmacology of the kallikrein-kinin system.
Pharmacological research : the official journal of the Italian Pharmacological Society 1997;35(6):513-5.
1997: Girolamo Calò; Anna Rizzi; M Bodin; W Neugebauer; Severo Salvadori; Remo Guerrini; Clementina Bianchi; Domenico Regoli
Pharmacological characterization of nociceptin receptor: an in vitro study.
Canadian journal of physiology and pharmacology 1997;75(6):713-8.
1997: Anna Rizzi; F Gobeil; G Bogoni; Girolamo Calò; C Campobasso; N Inamura; Domenico Regoli
Antagonistic effects of FR 173657 on human, pig, rabbit, and guinea pig kinin receptors: an in vitro study.
Canadian journal of physiology and pharmacology 1997;75(6):601-8.
1997: Anna Rizzi; F Gobeil; Girolamo Calò; N Inamura; Domenico Regoli
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study.
Hypertension 1997;29(4):951-6.
1997: Girolamo Calò; S Sbrenna; Clementina Bianchi; Lorenzo Beani
Immediate and delayed effects of in vitro ischemia on glutamate efflux from guinea-pig cerebral cortex slices.
Brain research 1997;751(2):300-6.
1997: Girolamo Calò; Anna Rizzi; L Traina; Domenico Regoli
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
Life sciences 1997;60(4-5):PL63-8.
1996: Girolamo Calò; Anna Rizzi; G Bogoni; V Neugebauer; Severo Salvadori; Remo Guerrini; Clementina Bianchi; D Regoli
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.
European journal of pharmacology 1996;311(1):R3-5.
1995: Massimo Gallerani; L Ricci; Roberto Manfredini; Girolamo Calò
Acute thrombosis of abdominal aorta in a patient undergoing warfarin treatment.
The American journal of emergency medicine 1995;13(5):617-8.
1994: Roberto Manfredini; Massimo Gallerani; Stefano Caracciolo; A Tomelli; Girolamo Calò; Carmelo Fersini
Circadian variation in attempted suicide by deliberate self poisoning.
BMJ (Clinical research ed.) 1994;309(6957):774-5.
1994: Roberto Manfredini; Massimo Gallerani; Raffaella Salmi; Girolamo Calò; M Pasin; M Bigoni; Carmelo Fersini
Circadian variation in the time of onset of acute gastrointestinal bleeding.
The Journal of emergency medicine 1994;12(1):5-9.
1992: Massimo Gallerani; Roberto Manfredini; L Ricci; E Grandi; R Cappato; Girolamo Calò; P L Pareschi; Carmelo Fersini
Sudden death from pulmonary thromboembolism: chronobiological aspects.
European heart journal 1992;13(5):661-5.